Krystal Biotech, Inc.
Hedge Funds Holdings
Last updated:
Krystal Biotech, Inc.‘s stocks are currently a part of 101 hedge funds’ portfolios, which represents 42.59% of the total amount of its stocks outstanding. This makes up a total of 10.85M shares of Krystal Biotech, Inc.. Compared to the previous quarter, the number fell by -48.05% or -10.04M shares fewer. As for the holding position changes, 33.66% (34) of current hedge fund investors increased the number of shares held, 37.62% (38) of current holders sold a part of the shares held, and 6.93% (7) closed the holdings completely. 9 hedge funds are new holders of Krystal Biotech, Inc. stock in Q1 2023, it is 8.91% of total holders.
Hedge funds holding Krystal Biotech (Q2 2018 – Q1 2023)
| Q2 2018 | 17 |
|---|---|
| Q3 2018 | 21 |
| Q4 2018 | 45 |
| Q1 2019 | 57 |
| Q2 2019 | 74 |
| Q3 2019 | 85 |
| Q4 2019 | 90 |
| Q1 2020 | 90 |
| Q2 2020 | 110 |
| Q3 2020 | 98 |
| Q4 2020 | 108 |
| Q1 2021 | 113 |
| Q2 2021 | 113 |
| Q3 2021 | 113 |
| Q4 2021 | 137 |
| Q1 2022 | 130 |
| Q2 2022 | 132 |
| Q3 2022 | 142 |
| Q4 2022 | 152 |
| Q1 2023 | 101 |
Hedge funds changes in Krystal Biotech positions (Q2 2018 – Q1 2023)
| Q2 2018 | 6 | 4 | 2 | 1 | 4 |
|---|---|---|---|---|---|
| Q3 2018 | 8 | 5 | 3 | 4 | 1 |
| Q4 2018 | 27 | 11 | 4 | 3 | 0 |
| Q1 2019 | 17 | 19 | 16 | 5 | 0 |
| Q2 2019 | 28 | 26 | 14 | 11 | -5 |
| Q3 2019 | 16 | 35 | 20 | 5 | 9 |
| Q4 2019 | 12 | 31 | 31 | 6 | 10 |
| Q1 2020 | 14 | 34 | 29 | 12 | 1 |
| Q2 2020 | 30 | 47 | 22 | 11 | 0 |
| Q3 2020 | 4 | 47 | 30 | 15 | 2 |
| Q4 2020 | 20 | 35 | 31 | 10 | 12 |
| Q1 2021 | 16 | 53 | 29 | 10 | 5 |
| Q2 2021 | 13 | 54 | 30 | 13 | 3 |
| Q3 2021 | 12 | 45 | 33 | 10 | 13 |
| Q4 2021 | 45 | 57 | 21 | 22 | -8 |
| Q1 2022 | 22 | 51 | 46 | 28 | -17 |
| Q2 2022 | 19 | 45 | 50 | 16 | 2 |
| Q3 2022 | 19 | 59 | 40 | 8 | 16 |
| Q4 2022 | 21 | 61 | 49 | 9 | 12 |
| Q1 2023 | 9 | 34 | 38 | 7 | 13 |
Hedge funds changes in Krystal Biotech stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 1,034,000 | 1,106,000 |
| Q3 2020 | 431,000 | 1,058,000 |
| Q4 2020 | 2,526,000 | 0 |
| Q1 2021 | 4,552,000 | 1,432,000 |
| Q2 2021 | 3,947,000 | 9,034,000 |
| Q3 2021 | 35,767,000 | 22,312,000 |
| Q4 2021 | 17,150,000 | 20,258,000 |
| Q1 2022 | 5,515,000 | 3,095,000 |
| Q2 2022 | 9,198,000 | 3,874,000 |
| Q3 2022 | 5,093,000 | 10,898,000 |
| Q4 2022 | 5,679,542 | 21,421,086 |
| Q1 2023 | 2,715,395,000 | 1,202,138,000 |